サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1508678

薬用ワイプ市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2032年

Medicated Wipes Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
薬用ワイプ市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2032年
出版日: 2024年07月02日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社は、薬用ワイプの世界市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題など、重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • 薬用ワイプの市場規模（2024年）：90億米ドル
  • 市場予測値（2032年）：147億米ドル
  • 世界市場成長率（CAGR 2024年～2032年）：6.3%：6.3%

薬用ワイプ市場 - 調査範囲：

薬用ワイプは、皮膚の洗浄、消毒、治療に便利で効果的なソリューションを提供し、個人の衛生とヘルスケアにおいて重要な役割を果たしています。これらのワイプには有効成分が配合されており、にきび、発疹、感染症など、さまざまな皮膚の状態に対処するのに役立ちます。同市場は、病院、診療所、皮膚科センター、小売消費者向けに、抗菌ワイプ、消毒ワイプ、治療用ワイプなど、さまざまな製品を提供しています。

市場成長の促進要因：

薬用ワイプの世界市場は、特にCOVID-19パンデミックを契機とした衛生・公衆衛生の意識の高まりなど、いくつかの重要な要因に後押しされています。にきびや湿疹などの皮膚疾患の有病率の上昇や、外出先でも使える便利なスキンケアソリューションへの需要が、市場拡大をさらに後押ししています。配合を強化したワイプや生分解性素材の開発といった技術の進歩は、効能の向上と環境の持続可能性を提供し、市場の成長を促進しています。さらに、ヘルスケア現場での薬用ワイプの採用の増加やeコマースプラットフォームの拡大は、市場企業がより幅広い消費者層にリーチするための新たな道を作り出しています。

市場抑制要因：

有望な成長見通しにもかかわらず、薬用ワイプ市場は規制遵守、製品の安全性、環境問題などに関する課題に直面しています。薬用ワイプの処方、製造、表示に関する厳しい規制は、メーカーにコンプライアンス上の負担を課し、市場参入障壁や運営コストに影響を与えます。さらに、使い捨てワイプの環境への影響や、皮膚刺激やアレルギーに対する懸念は、市場浸透の課題となっています。こうした規制や環境の障壁に対処するには、安全で効果的かつ持続可能な薬用ワイプへのアクセスを促進するために、業界利害関係者と政策立案者の協力が必要です。

市場機会：

薬用ワイプ市場は、技術革新、人口動向、消費者の嗜好の進化によって、大きな成長機会がもたらされます。アロエベラやティーツリーオイルなどの天然成分やオーガニック成分を配合することで、健康志向の消費者や敏感肌の消費者にとって薬用ワイプの魅力が高まる。さらに、創傷ケアや感染症対策など、スキンケア以外にも薬用ワイプの用途が広がることで、市場の幅が広がり、技術革新が促進されます。戦略的パートナーシップ、研究開発への投資、環境に優しく費用対効果の高い薬用ワイプのイントロダクションは、新たなビジネスチャンスを生かし、ダイナミックなヘルスケア市場においてリーダーシップを維持するために不可欠です。

本レポートで扱う主な質問

  • 世界の薬用ワイプ市場の成長を促進する主な要因は何か？
  • さまざまな消費者層で薬用ワイプの採用を促進している製品タイプと用途は何か？
  • 技術の進歩は薬用ワイプ市場の競合情勢をどのように変えているか？
  • 薬用ワイプ市場に貢献している主要企業はどこか、また市場の関連性を維持するためにどのような戦略をとっているのか？
  • 世界の薬用ワイプ市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 主要な成功要因

  • 製品の採用/使用状況分析
  • PESTEL分析
  • ポーターの分析
  • メーカー別の主なプロモーション戦略
  • 規制シナリオ

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別の収益
    • ソース別の収益
    • 流通チャネル別の収益
    • 国別の収益
  • 2024年の市場シナリオ

第7章 世界市場 - 価格分析

  • 製品別の地域別価格分析
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク

第8章 世界市場の需要（数量）分析

  • 過去の市場数量分析（2019年～2023年）
  • 現在および将来の市場数量予測（2024年～2032年）
    • 前年比成長動向分析

第9章 世界市場の需要分析

  • 過去の市場金額分析（2019年～2023年）
  • 現在および将来の市場金額予測（2024年～2032年）
    • 前年比成長動向分析
    • 絶対額の機会分析

第10章 世界市場分析：製品別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析：製品別（2019年～2023年）
  • 現在および将来の市場規模分析と予測：製品別（2024年～2032年）
    • 創傷ケア
    • 痔のケア
    • 皮膚科ケア
    • 女性ケア
    • その他
  • 製品別の市場の魅力分析

第11章 世界市場分析：ソース別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析：ソース別（2019年～2023年）
  • 現在および将来の市場規模分析と予測：ソース別（2024年～2032年）
    • ドライワイプ
    • ワイプ
  • ソース別の市場の魅力分析

第12章 世界市場分析：流通チャネル別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析：流通チャネル別（2019年～2023年）
  • 現在および将来の市場規模分析と予測：流通チャネル別（2024年～2032年）
    • 小売薬局
    • 病院薬局
    • オンライン販売
    • ハイパーマーケット/スーパーマーケット
  • 流通チャネル別の市場の魅力分析

第13章 世界市場分析：地域別

  • イントロダクション
  • 過去の市場規模分析：地域別（2019年～2023年）
  • 現在および将来の市場規模分析と予測：地域別（2024年～2032年）
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別の市場の魅力分析

第14章 北米市場分析

第15章 ラテンアメリカ市場分析

第16章 欧州市場分析

第17章 南アジア市場分析

第18章 東アジア市場分析

第19章 オセアニア市場分析

第20章 中東・アフリカ市場分析

第21章 市場構造分析

  • 企業階層別の市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合の詳細
    • Pfizer Inc.
    • Diamond Wipes International Inc.
    • Blistex Inc., Pure Touch Skin Care
    • GAMA Healthcare Ltd.
    • Kimberly-Clark Corporation
    • Johnson &Johnsom
    • Edgewell Personal Care
    • Rockline Industries
    • Procter &Gamble
    • 3M
    • Costco Wholesale Corporation
    • Reckitt Benckiser Group plc
    • Procotech Limited
    • Beiersdorf AG
    • Essity Aktiebolag（publ）
    • Cardinal Health
    • Medtronic
    • Stryker
    • Coloplast, Inc.
    • Hindustan Unilever Ltd.
    • Medline Industries Inc.
    • ConvaTec Inc.
    • The Himalaya Drug Company
    • Domtar Corporation
    • Hollister Incorporated
    • Godrej Consumer Products Limited.

第23章 前提と頭字語

第24章 調査手法

目次
Product Code: PMRREP33318

Persistence Market Research has recently released a comprehensive report on the worldwide market for medicated wipes. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Medicated Wipes Market Size (2024E): USD 9 Billion
  • Projected Market Value (2032F): USD 14.7 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 6.3%

Medicated Wipes Market - Report Scope:

Medicated wipes play a crucial role in personal hygiene and healthcare, providing convenient and effective solutions for skin cleansing, disinfecting, and treatment. These wipes are infused with active ingredients that help address various skin conditions, including acne, rashes, and infections. The market caters to hospitals, clinics, dermatology centers, and retail consumers, offering a range of products, including antibacterial wipes, antiseptic wipes, and therapeutic wipes.

Market Growth Drivers:

The global medicated wipes market is propelled by several key factors, including increasing awareness about hygiene and sanitation, particularly in the wake of the COVID-19 pandemic. The rising prevalence of skin conditions, such as acne and eczema, and the demand for convenient, on-the-go skincare solutions further drive market expansion. Technological advancements, such as the development of wipes with enhanced formulations and biodegradable materials, offer improved efficacy and environmental sustainability, fostering market growth. Moreover, the increasing adoption of medicated wipes in healthcare settings and the expansion of e-commerce platforms create new avenues for market players to reach a wider consumer base.

Market Restraints:

Despite promising growth prospects, the medicated wipes market faces challenges related to regulatory compliance, product safety, and environmental concerns. Stringent regulations governing the formulation, manufacturing, and labeling of medicated wipes impose compliance burdens on manufacturers, affecting market entry barriers and operational costs. Furthermore, the environmental impact of disposable wipes and concerns over skin irritation and allergies pose challenges for market penetration. Addressing these regulatory and environmental barriers requires collaboration between industry stakeholders and policymakers to promote access to safe, effective, and sustainable medicated wipes.

Market Opportunities:

The medicated wipes market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving consumer preferences. The integration of natural and organic ingredients, such as aloe vera and tea tree oil, enhances the appeal of medicated wipes to health-conscious consumers and those with sensitive skin. Furthermore, the expanding application of medicated wipes beyond skincare, including in wound care and infection control, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of eco-friendly, cost-effective medicated wipes are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic healthcare landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the medicated wipes market globally?
  • Which product types and applications are driving medicated wipes adoption across different consumer segments?
  • How are technological advancements reshaping the competitive landscape of the medicated wipes market?
  • Who are the key players contributing to the medicated wipes market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global medicated wipes market?

Competitive Intelligence and Business Strategy:

Leading players in the global medicated wipes market, including Johnson & Johnson, Procter & Gamble, and Reckitt Benckiser, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced formulations, including alcohol-free and hypoallergenic wipes, catering to diverse consumer needs and skin types. Collaborations with healthcare providers, retailers, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and consumer education fosters market growth and enhances user outcomes in the rapidly evolving healthcare landscape.

Key Companies Profiled:

  • Pfizer Inc.
  • Diamond Wipes International Inc.
  • Blistex Inc., Pure Touch Skin Care
  • GAMA Healthcare Ltd.
  • Kimberly-Clark Corporation
  • Johnson & Johnson
  • Edgewell Personal Care
  • Rockline Industries
  • Procter & Gamble
  • 3M
  • Costco Wholesale Corporation
  • Reckitt Benckiser Group plc
  • Procotech Limited
  • Beiersdorf AG
  • Essity Aktiebolag (publ)
  • Cardinal Health
  • Medtronic
  • Stryker
  • Coloplast, Inc.

Medicated Wipes Market Research Segmentation

By Product:

  • Wound Care
  • Hemorrhoid Care
  • Dermatological Care
  • Feminine Care

By Source:

  • Dry Wipes
  • Wet Wipes

By Distribution Channel:

  • Retail Pharmacies
  • Hospital pharmacies
  • Online Platforms
  • Hypermarkets/Supermarkets

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption/Usage Analysis
  • 4.2. PESTEL Analysis
  • 4.3. Porter's Analysis
  • 4.4. Key Promotional Strategies, by Manufacturers
  • 4.5. Regulatory Scenario

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growing Application of Wipes in Various End User Industries
    • 5.2.2. Rise in R&D Activities
    • 5.2.3. Growing Demand For Medicated Wipes
    • 5.2.4. Rise In Prevalence Of Haemorrhoids
    • 5.2.5. Rebound in Manufacturing Activity and an Acceleration in Consumer Spending
    • 5.2.6. Availability of Other Substitute Products
    • 5.2.7. Rising Usage Of Bio-Degradable material for Sustainable Production of Medicated Wipes
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Product
    • 6.1.2. Revenue By Source
    • 6.1.3. Revenue By Distribution Channel
    • 6.1.4. Revenue By Country
  • 6.2. 2024 Market Scenario

7. Global Market - Pricing Analysis

  • 7.1. Regional Pricing Analysis By Product
  • 7.2. Pricing Break-up
    • 7.2.1. Manufacturer Level Pricing
    • 7.2.2. Distributor Level Pricing
  • 7.3. Global Average Pricing Analysis Benchmark

8. Global Market Demand (Volume in units) Analysis 2019-2023 and Forecast, 2024-2032

  • 8.1. Historical Market Volume (in units) Analysis, 2019-2023
  • 8.2. Current and Future Market Volume (in units) Projections, 2024-2032
    • 8.2.1. Y-o-Y Growth Trend Analysis

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2032

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2032
    • 10.3.1. Wound Care
    • 10.3.2. Haemorrhoid Care
    • 10.3.3. Dermatological Care
    • 10.3.4. Feminine Care
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Source

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Source, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Source, 2024-2032
    • 11.3.1. Dry Wipes
    • 11.3.2. Wet Wipes
  • 11.4. Market Attractiveness Analysis By Source

12. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Distribution Channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2024-2032
    • 12.3.1. Retail Pharmacies
    • 12.3.2. Hospital Pharmacies
    • 12.3.3. Online Sales
    • 12.3.4. Hypermarket/Supermarket
  • 12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Source
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Source
    • 14.4.4. By Distribution Channel
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Market Trends
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Source
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Canada Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Source
        • 14.8.2.2.3. By Distribution Channel

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Source
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Source
    • 15.4.4. By Distribution Channel
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Market Trends
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Brazil Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Source
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Argentina Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Source
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. Mexico Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Source
        • 15.8.3.2.3. By Distribution Channel

16. Europe Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Nordic Countries
      • 16.3.1.8. Russia
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Source
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Source
    • 16.4.4. By Distribution Channel
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Market Trends
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Source
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. France Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Source
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. Italy Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Source
        • 16.8.3.2.3. By Distribution Channel
    • 16.8.4. Spain Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Source
        • 16.8.4.2.3. By Distribution Channel
    • 16.8.5. U.K. Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Source
        • 16.8.5.2.3. By Distribution Channel
    • 16.8.6. Benelux Union Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Source
        • 16.8.6.2.3. By Distribution Channel
    • 16.8.7. Russia Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Source
        • 16.8.7.2.3. By Distribution Channel

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Source
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Source
    • 17.4.4. By Distribution Channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Market Trends
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Source
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. Indonesia Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Source
        • 17.8.2.2.3. By Distribution Channel
    • 17.8.3. Malaysia Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Source
        • 17.8.3.2.3. By Distribution Channel
    • 17.8.4. Thailand Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Source
        • 17.8.4.2.3. By Distribution Channel

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By Source
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Source
    • 18.4.4. By Distribution Channel
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. China Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Source
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Japan Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Source
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. South Korea Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Source
        • 18.8.3.2.3. By Distribution Channel

19. Oceania Market Analysis 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Source
    • 19.3.4. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Source
    • 19.4.4. By Distribution Channel
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Market Trends
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Source
        • 19.8.1.2.3. By Distribution Channel
    • 19.8.2. New Zealand Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Source
        • 19.8.2.2.3. By Distribution Channel

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Source
    • 20.3.4. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Source
    • 20.4.4. By Distribution Channel
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Market Trends
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Market
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Source
        • 20.8.1.2.3. By Distribution Channel
    • 20.8.2. Turkiye Market
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Source
        • 20.8.2.2.3. By Distribution Channel
    • 20.8.3. South Africa Market
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Source
        • 20.8.3.2.3. By Distribution Channel

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis
    • 21.3.1. Regional footprint of Players
    • 21.3.2. Platform Type foot print by Players
    • 21.3.3. Channel Foot Print by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Deep Dive
    • 22.2.1. Pfizer Inc.
      • 22.2.1.1. Overview & Key financials
      • 22.2.1.2. R& D Expenditure
      • 22.2.1.3. Sales Footprint
      • 22.2.1.4. Key Financial
      • 22.2.1.5. SWOT Analysis
      • 22.2.1.6. Strategy Overview
        • 22.2.1.6.1. Marketing Strategy
        • 22.2.1.6.2. Drug Strategy
        • 22.2.1.6.3. Channel Strategy
    • 22.2.2. Diamond Wipes International Inc.
      • 22.2.2.1. Overview & Key financials
      • 22.2.2.2. R& D Expenditure
      • 22.2.2.3. Sales Footprint
      • 22.2.2.4. Key Financial
      • 22.2.2.5. SWOT Analysis
      • 22.2.2.6. Strategy Overview
        • 22.2.2.6.1. Marketing Strategy
        • 22.2.2.6.2. Drug Strategy
        • 22.2.2.6.3. Channel Strategy
    • 22.2.3. Blistex Inc., Pure Touch Skin Care
      • 22.2.3.1. Overview & Key financials
      • 22.2.3.2. R& D Expenditure
      • 22.2.3.3. Sales Footprint
      • 22.2.3.4. Key Financial
      • 22.2.3.5. SWOT Analysis
      • 22.2.3.6. Strategy Overview
        • 22.2.3.6.1. Marketing Strategy
        • 22.2.3.6.2. Drug Strategy
        • 22.2.3.6.3. Channel Strategy
    • 22.2.4. GAMA Healthcare Ltd.
      • 22.2.4.1. Overview & Key financials
      • 22.2.4.2. R& D Expenditure
      • 22.2.4.3. Sales Footprint
      • 22.2.4.4. Key Financial
      • 22.2.4.5. SWOT Analysis
      • 22.2.4.6. Strategy Overview
        • 22.2.4.6.1. Marketing Strategy
        • 22.2.4.6.2. Drug Strategy
        • 22.2.4.6.3. Channel Strategy
    • 22.2.5. Kimberly-Clark Corporation
      • 22.2.5.1. Overview & Key financials
      • 22.2.5.2. R& D Expenditure
      • 22.2.5.3. Sales Footprint
      • 22.2.5.4. Key Financial
      • 22.2.5.5. SWOT Analysis
      • 22.2.5.6. Strategy Overview
        • 22.2.5.6.1. Marketing Strategy
        • 22.2.5.6.2. Drug Strategy
        • 22.2.5.6.3. Channel Strategy
    • 22.2.6. Johnson & Johnsom
      • 22.2.6.1. Overview & Key financials
      • 22.2.6.2. R& D Expenditure
      • 22.2.6.3. Sales Footprint
      • 22.2.6.4. Key Financial
      • 22.2.6.5. SWOT Analysis
      • 22.2.6.6. Strategy Overview
        • 22.2.6.6.1. Marketing Strategy
        • 22.2.6.6.2. Drug Strategy
        • 22.2.6.6.3. Channel Strategy
    • 22.2.7. Edgewell Personal Care
      • 22.2.7.1. Overview & Key financials
      • 22.2.7.2. R& D Expenditure
      • 22.2.7.3. Sales Footprint
      • 22.2.7.4. Key Financial
      • 22.2.7.5. SWOT Analysis
      • 22.2.7.6. Strategy Overview
        • 22.2.7.6.1. Marketing Strategy
        • 22.2.7.6.2. Drug Strategy
        • 22.2.7.6.3. Channel Strategy
    • 22.2.8. Rockline Industries
      • 22.2.8.1. Overview & Key financials
      • 22.2.8.2. R& D Expenditure
      • 22.2.8.3. Sales Footprint
      • 22.2.8.4. Key Financial
      • 22.2.8.5. SWOT Analysis
      • 22.2.8.6. Strategy Overview
        • 22.2.8.6.1. Marketing Strategy
        • 22.2.8.6.2. Drug Strategy
        • 22.2.8.6.3. Channel Strategy
    • 22.2.9. Procter & Gamble
      • 22.2.9.1. Overview & Key financials
      • 22.2.9.2. R& D Expenditure
      • 22.2.9.3. Sales Footprint
      • 22.2.9.4. Key Financial
      • 22.2.9.5. SWOT Analysis
      • 22.2.9.6. Strategy Overview
        • 22.2.9.6.1. Marketing Strategy
        • 22.2.9.6.2. Drug Strategy
        • 22.2.9.6.3. Channel Strategy
    • 22.2.10. 3M
      • 22.2.10.1. Overview & Key financials
      • 22.2.10.2. R& D Expenditure
      • 22.2.10.3. Sales Footprint
      • 22.2.10.4. Key Financial
      • 22.2.10.5. SWOT Analysis
      • 22.2.10.6. Strategy Overview
        • 22.2.10.6.1. Marketing Strategy
        • 22.2.10.6.2. Drug Strategy
        • 22.2.10.6.3. Channel Strategy
    • 22.2.11. Costco Wholesale Corporation
      • 22.2.11.1. Overview & Key financials
      • 22.2.11.2. R& D Expenditure
      • 22.2.11.3. Sales Footprint
      • 22.2.11.4. Key Financial
      • 22.2.11.5. SWOT Analysis
      • 22.2.11.6. Strategy Overview
        • 22.2.11.6.1. Marketing Strategy
        • 22.2.11.6.2. Drug Strategy
        • 22.2.11.6.3. Channel Strategy
    • 22.2.12. Reckitt Benckiser Group plc
      • 22.2.12.1. Overview & Key financials
      • 22.2.12.2. R& D Expenditure
      • 22.2.12.3. Sales Footprint
      • 22.2.12.4. Key Financial
      • 22.2.12.5. SWOT Analysis
      • 22.2.12.6. Strategy Overview
        • 22.2.12.6.1. Marketing Strategy
        • 22.2.12.6.2. Drug Strategy
        • 22.2.12.6.3. Channel Strategy
    • 22.2.13. Procotech Limited
      • 22.2.13.1. Overview & Key financials
      • 22.2.13.2. R& D Expenditure
      • 22.2.13.3. Sales Footprint
      • 22.2.13.4. Key Financial
      • 22.2.13.5. SWOT Analysis
      • 22.2.13.6. Strategy Overview
        • 22.2.13.6.1. Marketing Strategy
        • 22.2.13.6.2. Drug Strategy
        • 22.2.13.6.3. Channel Strategy
    • 22.2.14. Beiersdorf AG
      • 22.2.14.1. Overview & Key financials
      • 22.2.14.2. R& D Expenditure
      • 22.2.14.3. Sales Footprint
      • 22.2.14.4. Key Financial
      • 22.2.14.5. SWOT Analysis
      • 22.2.14.6. Strategy Overview
        • 22.2.14.6.1. Marketing Strategy
        • 22.2.14.6.2. Drug Strategy
        • 22.2.14.6.3. Channel Strategy
    • 22.2.15. Essity Aktiebolag (publ)
      • 22.2.15.1. Overview & Key financials
      • 22.2.15.2. R& D Expenditure
      • 22.2.15.3. Sales Footprint
      • 22.2.15.4. Key Financial
      • 22.2.15.5. SWOT Analysis
      • 22.2.15.6. Strategy Overview
        • 22.2.15.6.1. Marketing Strategy
        • 22.2.15.6.2. Drug Strategy
        • 22.2.15.6.3. Channel Strategy
    • 22.2.16. Cardinal Health
      • 22.2.16.1. Overview & Key financials
      • 22.2.16.2. R& D Expenditure
      • 22.2.16.3. Sales Footprint
      • 22.2.16.4. Key Financial
      • 22.2.16.5. SWOT Analysis
      • 22.2.16.6. Strategy Overview
        • 22.2.16.6.1. Marketing Strategy
        • 22.2.16.6.2. Drug Strategy
        • 22.2.16.6.3. Channel Strategy
    • 22.2.17. Medtronic
      • 22.2.17.1. Overview & Key financials
      • 22.2.17.2. R& D Expenditure
      • 22.2.17.3. Sales Footprint
      • 22.2.17.4. Key Financial
      • 22.2.17.5. SWOT Analysis
      • 22.2.17.6. Strategy Overview
        • 22.2.17.6.1. Marketing Strategy
        • 22.2.17.6.2. Drug Strategy
        • 22.2.17.6.3. Channel Strategy
    • 22.2.18. Stryker
      • 22.2.18.1. Overview & Key financials
      • 22.2.18.2. R& D Expenditure
      • 22.2.18.3. Sales Footprint
      • 22.2.18.4. Key Financial
      • 22.2.18.5. SWOT Analysis
      • 22.2.18.6. Strategy Overview
        • 22.2.18.6.1. Marketing Strategy
        • 22.2.18.6.2. Drug Strategy
        • 22.2.18.6.3. Channel Strategy
    • 22.2.19. Coloplast, Inc.
      • 22.2.19.1. Overview & Key financials
      • 22.2.19.2. R& D Expenditure
      • 22.2.19.3. Sales Footprint
      • 22.2.19.4. Key Financial
      • 22.2.19.5. SWOT Analysis
      • 22.2.19.6. Strategy Overview
        • 22.2.19.6.1. Marketing Strategy
        • 22.2.19.6.2. Drug Strategy
        • 22.2.19.6.3. Channel Strategy
    • 22.2.20. Hindustan Unilever Ltd.
      • 22.2.20.1. Overview & Key financials
      • 22.2.20.2. R& D Expenditure
      • 22.2.20.3. Sales Footprint
      • 22.2.20.4. Key Financial
      • 22.2.20.5. SWOT Analysis
      • 22.2.20.6. Strategy Overview
        • 22.2.20.6.1. Marketing Strategy
        • 22.2.20.6.2. Drug Strategy
        • 22.2.20.6.3. Channel Strategy
    • 22.2.21. Medline Industries Inc.
      • 22.2.21.1. Overview & Key financials
      • 22.2.21.2. R& D Expenditure
      • 22.2.21.3. Sales Footprint
      • 22.2.21.4. Key Financial
      • 22.2.21.5. SWOT Analysis
      • 22.2.21.6. Strategy Overview
        • 22.2.21.6.1. Marketing Strategy
        • 22.2.21.6.2. Drug Strategy
        • 22.2.21.6.3. Channel Strategy
    • 22.2.22. ConvaTec Inc.
      • 22.2.22.1. Overview & Key financials
      • 22.2.22.2. R& D Expenditure
      • 22.2.22.3. Sales Footprint
      • 22.2.22.4. Key Financial
      • 22.2.22.5. SWOT Analysis
      • 22.2.22.6. Strategy Overview
        • 22.2.22.6.1. Marketing Strategy
        • 22.2.22.6.2. Drug Strategy
        • 22.2.22.6.3. Channel Strategy
    • 22.2.23. The Himalaya Drug Company
      • 22.2.23.1. Overview & Key financials
      • 22.2.23.2. R& D Expenditure
      • 22.2.23.3. Sales Footprint
      • 22.2.23.4. Key Financial
      • 22.2.23.5. SWOT Analysis
      • 22.2.23.6. Strategy Overview
        • 22.2.23.6.1. Marketing Strategy
        • 22.2.23.6.2. Drug Strategy
        • 22.2.23.6.3. Channel Strategy
    • 22.2.24. Domtar Corporation
      • 22.2.24.1. Overview & Key financials
      • 22.2.24.2. R& D Expenditure
      • 22.2.24.3. Sales Footprint
      • 22.2.24.4. Key Financial
      • 22.2.24.5. SWOT Analysis
      • 22.2.24.6. Strategy Overview
        • 22.2.24.6.1. Marketing Strategy
        • 22.2.24.6.2. Drug Strategy
        • 22.2.24.6.3. Channel Strategy
    • 22.2.25. Hollister Incorporated
      • 22.2.25.1. Overview & Key financials
      • 22.2.25.2. R& D Expenditure
      • 22.2.25.3. Sales Footprint
      • 22.2.25.4. Key Financial
      • 22.2.25.5. SWOT Analysis
      • 22.2.25.6. Strategy Overview
        • 22.2.25.6.1. Marketing Strategy
        • 22.2.25.6.2. Drug Strategy
        • 22.2.25.6.3. Channel Strategy
    • 22.2.26. Godrej Consumer Products Limited.
      • 22.2.26.1. Overview & Key financials
      • 22.2.26.2. R& D Expenditure
      • 22.2.26.3. Sales Footprint
      • 22.2.26.4. Key Financial
      • 22.2.26.5. SWOT Analysis
      • 22.2.26.6. Strategy Overview
        • 22.2.26.6.1. Marketing Strategy
        • 22.2.26.6.2. Drug Strategy
        • 22.2.26.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology